Instrument Inactif

Communiqués Cytosorbents Corp OTC Bulletin Board

Actions

CTSO

US23283X1072

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

CytoSorbents: Q1 Earnings Snapshot	09/05	AQ
CytoSorbents Reports First Quarter 2024 Results	09/05	GL
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe	02/05	GL
CytoSorbents to Report First Quarter 2024 Operating and Financial Results	26/04	GL
STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting	17/04	GL
CytoSorbents Reports Fourth Quarter and Full Year 2023 Results	14/03	GL
CytoSorbents to Report Fiscal 2023 Operating and Financial Results	06/03	GL
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02	GL
CytoSorbents to Present at the TD Cowen 44th Annual Health Care Conference	08/02	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	31/01	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	23/01	PR
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01	GL
Groundbreaking Randomized Controlled Trial Reports Excellent Clinical Outcomes Using CytoSorb® Intraoperatively in Heart Transplant Patients	17/01	AQ
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	14/01	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	06/01	PR
Pomerantz Law Firm Investigates Claims on Behalf of Investors of Cytosorbents Corporation - CTSO	29/12	PR
CytoSorbents Provides Update on the STAR-T Trial and Reports Final Independent Data and Safety Monitoring Board Recommendation	28/12	GL
CytoSorbents Announces Closing of $10.3 Million Registered Direct Offering	13/12	GL
CytoSorbents: Q3 Earnings Snapshot	09/11	AQ
CytoSorbents Reports Third Quarter 2023 Financial and Operational Results	09/11	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Cytosorbents Corp OTC Bulletin Board

Actions

CTSO

US23283X1072

Communiqués

Filtres